
Opinion|Videos|August 21, 2024
Treatment Options in Castration-Resistant Prostate Cancer
Focusing on castration-resistant prostate cancer, the panel reviews treatment options for patients with metastatic and nonmetastatic disease.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves enfortumab vedotin plus pembrolizumab for MIBC
2
Study suggests tamsulosin deprescribing may be appropriate for select men with BPH
3
Trial launches of actinium (225Ac) rhPSMA-10.1 injection in mCRPC
4
Urocross shows sustained benefit through 24 months post-removal
5















